Evaluation of Left Ventricular Function, Contractility and Ejection Fraction in COPD Patients by Echocardiography
Abstract
Chronic obstructive pulmonary disease (COPD) is a major cause of chronic morbidity and mortality throughout the world. According to global initiative for chronic obstructive lung disease, COPD is defined as FEV1/FVC<70% by spirometry. COPD affects pulmonary blood vessels, right ventricle as well as left ventricle, leading to development of pulmonary hypertension, cor-pulmonale, right ventricular dysfunction as well as left ventricular dysfunction. The significance of the right ventricular performance is recognized as one of the factors determining the clinical course and prognosis in COPD, but a potential role of the left ventricle is, however, less studied. The aim of this study was primarily to evaluate left ventricular function in COPD patients by echocardiography and to study the correlation between echocardiography findings and the severity of COPD based on GOLD1 criteria. A total of 100 patients were selected for this study, including 72 male patients and 28 female patients, aged 50–70 years, from outpatient department of medicine department, medical wards, TB and chest ward of Dr Baba Sahib Ambedkar Hospital, Delhi, considering the exclusion and inclusion criteria. In mild COPD group, only one patient was found to have systolic dysfunction out of 52 patients (1.92%), in moderate COPD group, 2 patients had systolic dysfunction out of 32 patients (6.25%), whereas in severe COPD, six patients had systolic dysfunction out of 16 patients (37.5%). So, in total, 9% patients had systolic dysfunction.
28% of patients were found to have left ventricular diastolic dysfunction in our study. COPD patients have a high prevalence of left ventricular diastolic dysfunction, which is associated with disease severity.
A clear correlation was found between value of fractional shortening (FS) of left ventricle (a measure of contractility), and severity of COPD and FS value significantly decreased as the severity of COPD increased.
In this study, ejection fraction (EF) was found to be preserved in mild and moderate COPD, albeit mean EF was found to be reduced in moderate COPD. In severe COPD group, EF was significantly lowered.
Keywords
Full Text:
PDFReferences
GOLD. Global strategy for the diagnosis, management,
and prevention of chronic obstructive pulmonary
disease: GOLD Executive Summary. [Last update on
Feb 21]. Available from: http:.
Burgess M, Mogulkoc N, Wright TR et al. Comparison of
echocardiographic markers of right ventricular function
in determining prognosis in chronic pulmonary disease.
J Am Soc Ecocardiogr 2002; 15: 633-39.
Schena M, Clini E, Errera D et al. Echo-Doppler
evaluation of left ventricular impairment in chronic
corpulmonale. Chest 1996; 109: 1446-45.
O’brien C, Guest PJ. Physiological and radiological
characterisation of patients with chronic obstructive
pulmonary disease in primary care. Thorax 2000; 55:
-42.
Rabab A, El Wahsha Mahmoud K, Ahmed Rehab Yasee.
Evaluation of left ventricular function in patients with
chronic obstructive pulmonary disease with or without
pulmonary hypertension. Egyptian Journal of Chest
Diseases and Tuberculosis Oct 2013; 62(4): 575-82.
Gaude GS, Suresh G, Mahishale V. Left ventricular
dysfunction and its correlates in chronic obstructive
pulmonary disease patients. Afr J Med Health
Sci [serial online] 2015 [cited 2018 Apr 5];14:87-
Available from: http://www.ajmhs.org/text.
asp?2015/14/2/87/170165.
Gupta NK, Agrawal RK, Srivastav AB et al.
Echocardiographic evaluation of heart in chronic
obstructive pulmonary disease patient and its corelation
with the severity of disease. Lung India 2011;
: 105-09.
Kaushal M, Shah PS, Shah AD et al. Chronic obstructive
pulmonary disease and cardiac comorbidities: A crosssectional
study. Lung India : Official Organ of Indian
Chest Society 2016; 33(4): 404-09.
Gupta NK, Agrawal RK, Srivastav AB et al.
Echocardiographic evaluation of heart in chronic
obstructive pulmonary disease patient and its corelation
with the severity of disease. Lung India 2011;
: 105-09.
Paulus WJ, Tschöpe C. A novel paradigm for heart
failure with preserved ejection fraction: comorbidities
drive myocardial dysfunction and remodeling through
coronary microvascular endothelial inflammation. J
Am Coll Cardiol.
Chaouat A, Naeije R, Weitzenblum E. Pulmonary
hypertension in COPD. Eur Respir J. 2008; 32: 1371-85.
Chatila WM, Thomashow BM, Minai OA et al.
Comorbidities in chronic obstructive pulmonary
disease. Proc Am Thorac Soc. 2008; 5: 549-55.
Garcia MJ. Diagnostico y guiaterapeutica de la
insuficiencia diastolica. Rev Esp Cardiol. 2093; 56:
-406.
Funk GC, LangI Schenk P, Valipour A et al. Left ventricular
diastolic dysfunction in patients with COPD in the
presence and absence of elevated pulmonary arterial
pressure. Chest 2008; 133: 1354.
Steele P, Ellis JH, Van Dyke D et al. Left ventricular
ejection fraction in severe chronic obstructive airways
disease. Am J Med 1975; 59: 21-28.
McCullough PA, Hollander JE, Nowak RM et al. BNP
Multinational Study Investigators. Uncovering heart
failure in patients with a history of pulmonary disease:
Rationale for the early use of B-type natriuretic peptide
in the emergency department. Acad Emerg Med. 2003;
: 198-204.
Refbacks
- There are currently no refbacks.
Copyright (c) 2018 Journal of Advanced Research in Medicine (P-ISSN:2394-7047 & E-ISSN:2349-7181)